You agree to the terms of service below, and the Terms of Use for Substack, the technology provider.

Terms of Service

Last updated: [23/5/25]

Welcome to Decode Your Diagnosis™ (DYD), a platform dedicated to providing education, inspiration, and support to individuals navigating chronic conditions. By accessing or using our website, newsletter, programs, or affiliated services, you agree to the following terms:

1. Educational Use Only

Decode Your Diagnosis is not a medical service. All content, including newsletters, articles, audio, video, AI-generated responses, and coaching materials, is for informational and educational purposes only. It should not be considered a substitute for professional medical advice, diagnosis, or treatment.

2. Community Conduct

We are committed to creating a safe, respectful space. By participating in our comment sections, chatrooms (e.g., The Common Fire), or community events, you agree to:

  • Refrain from offering medical treatment advice to others.

  • Avoid posting intolerant, inflammatory, or demoralizing comments.

  • Respect the privacy and dignity of other participants.

Violations may result in removal from the platform.

3. Subscriptions & Payments

If you choose to upgrade to a paid plan (Arena Inner Ring™), your subscription will renew automatically unless canceled prior to the renewal date. Refunds are not guaranteed but may be considered on a case-by-case basis.

4. Intellectual Property

All content on Decode Your Diagnosis, including written materials, artwork, and design, is owned by Paul Cobbin unless otherwise stated. You may not copy, republish, or redistribute material without permission.

5. Limitation of Liability

Decode Your Diagnosis is not liable for any direct, indirect, incidental, or consequential damages arising from your use of the platform. Always consult with a qualified health provider for personal medical needs.

6. Changes to Terms

We may revise these Terms from time to time. Continued use of our services after changes indicates acceptance of the new terms.

If you have any concerns please message us at the following link: